1. The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation
   Kandi Xu et al, 2021, Frontiers in Oncology CrossRef
2. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
   Huan Feng et al, 2020, Frontiers in Molecular Biosciences CrossRef
3. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
   Federica Saponaro et al, 2020, Frontiers in Molecular Biosciences CrossRef
4. 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging
   Fangyuan Ren et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
5. COVID-19 As An Endothelial Disease and Its Relationship to Vascular Endothelial Growth Factor (VEGF) and Iodide
   Mika Turkia, SSRN Electronic Journal CrossRef
6. Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
   Seyyed M. R. Kazemi-Bajestani et al, 2012, Cardiology Research and Practice CrossRef
7. The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
   Juanjuan Xu et al, 2017, Frontiers in Physiology CrossRef
8. Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism
   Jiawen Lv et al, 2024, ACS Applied Materials & Interfaces CrossRef
9. New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
   Anderson J. Ferreira et al, 2012, International Journal of Hypertension CrossRef
10. The Surging Mechanistic Role of Angiotensin Converting Enzyme 2 in Human Pathologies: A Potential Approach for Herbal Therapeutics
    Priyadarshini Gupta et al, 2023, Current Drug Targets CrossRef
11. Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients?
    Anem Iftikhar et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
12. Angiotensin Converting Enzyme-2 (ACE-2): A Target for Novel Drug Development
    Mit Joshi et al, 2024, Environmental Factors in the Pathogenesis of Cardiovascular Diseases CrossRef
13. Risk of lung cancer and renin–angiotensin blockade: a concise review
    Tobias Rachow et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
14. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response
    Serhiy Souchelnytskyi et al, 2021, Scientific Reports CrossRef
15. Evaluation of 68Ga- and 177Lu-Labeled HZ20 Angiotensin-Converting Enzyme 2-Targeting Peptides for Tumor-Specific Imaging
    Qian Zhang et al, 2022, Molecular Pharmaceutics CrossRef
16. 20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1
    Yuchen Wang et al, 2019, Frontiers in Pharmacology CrossRef